# OnCo record polaris-group (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/polaris-group/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "polaris-group" ;
  schema:name "Polaris Group"@en ;
  schema:alternateName "Polaris Pharmaceuticals"@en, "Polaris Pharmaceuticals, Inc."@en ;
  schema:description "Polaris Group develops pegargiminase (ADI-PEG 20), an enzyme that starves tumours lacking argininosuccinate synthetase of arginine, which improved survival in pleural mesothelioma in the phase 3 ATOMIC-Meso trial."@en ;
  schema:url <https://onco.cc/companies/polaris-group/>, <https://www.polarispharma.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://www.polarispharma.com>, <https://clinicaltrials.gov/search?lead=Polaris%20Group> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/mesothelioma/>, <https://onco.cc/cancers/hcc/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:drugs <https://onco.cc/drugs/adi-peg20/> ;
  onco:trials <https://onco.cc/trials/nct04587830/> .